1. Home
  2. Material Detail: FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US

Material Detail

FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US

FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US

This presentation provides an overview of how the biosimilars are developed and approved by the FDA.

Keywords:
cancer, Biosimilars
Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Presentation
Date Added to MERLOT:
July 9, 2020
Date Modified in MERLOT:
April 9, 2021
Author:
Submitter:
Laura Kavanagh
Primary Audience:
College Upper Division, Graduate School, Professional
Technical Format:
PDF
Mobile Compatibility:
Not specified at this time
Language:
English
Cost Involved:
No
Source Code Available:
Unknown
Creative Commons:
Unknown

Browse...

Disciplines with similar materials as FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US
People who viewed this also viewed
Other materials like FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.